Last updated on June 2018

Type 2 Diabetes – Add-On Therapy for Metformin

Brief description of study

Type 2 Diabetes – Add-On Therapy for Metformin

Detailed Study Description

A research study is evaluating an investigational medication for type 2 diabetes in patients who are currently taking metformin (only).


This research study may be an option if you: 

• Have been diagnosed with type 2 diabetes

• Are currently on a stable dose of Metformin and are having difficulty controlling your blood sugar levels (HbA1C)

• Have not taken any diabetes medications other than metformin in the last 12 weeks

• Have an HbA1C between 7.0% and 10.0%

• Have a Body Mass Index (BMI) between 20 and 45. Find out your BMI here 


Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Financial compensation may be provided for time and travel expenses.  

Clinical Study Identifier: TX154764

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.